News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
GLP-1s lowers risk of 10 obesity-associated cancers
Photo taken from medicalnewstoday.com
Jul 9, 2024, 10:44

GLP-1s lowers risk of 10 obesity-associated cancers

Ron DePinho, Professor and Past President of MD Anderson Cancer Center, shared a post on X:

“HUGE NEWS: GLP-1s lowered risk of 10 obesity-associated cancers. Compared to insulin, GLP-1s decreased in 10 of 13 cancers – 65% reduction in gallbladder cancer, 59% in pancreatic cancer, and 53% in hepatocellular carcinoma.”

Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes

Authors: Lindsey Wang, Rong Xu, David C. Kaelber and Nathan A. Berger.

GLP-1s lowers risk of 10 obesity-associated cancers

Source: Ron DePinho/X

cancer David C. Kaelber gallbladder cancer GLP-1s hepatocellular carcinoma Lindsey Wang MD Anderson Cancer Center Nathan A. Berger obesity-associated cancers OncoDaily Oncology Pancreatic Cancer Ron DePinho Rong Xu
Special Coverage
Blog
Dec 22, 2024, 05:05
Ruben Mesa: Excited to visit Atrium Health Levine Cancer Pineville
Blog
Dec 22, 2024, 05:02
Muhammad Umair Mushtaq: Are Stem Cell Transplants Safe for Myelofibrosis Patients Over 70?
Blog
Dec 22, 2024, 05:00
Elvina Almuradova: Being a part of Giuseppe Curigliano's team is an invaluable scientific milestone for me
Blog
Dec 22, 2024, 04:58
Summary slide for PFS in selected trials by IGHV status caveat for CLL by Nitin Jain
Insight
Dec 22, 2024, 04:53
Cancer survivors are growing in number - National Cancer Institute
Blog
Dec 22, 2024, 04:52
Registration is open for the ESMO Gastrointestinal Cancers Congress 2025
Blog
Dec 22, 2024, 04:49
Amalya Sargsyan: New ESO Rare Cancer Series podcast with Salvatore Provenzano
Insight
Dec 22, 2024, 04:47
Journal of Psychosocial Oncology Research and Practice: Vol. 6, Number 4 - IPOS
Science
Dec 22, 2024, 04:40
The prevalence of widespread guideline-discordant LDCT screening in a low-risk population by So Yeon Kim et al.
Blog
Dec 22, 2024, 04:38
The new Institute of Cancer Research spinout company Sentinal4D has been announced to the public
Blog
Dec 22, 2024, 04:34
Nermean Mostafa: Honored to co-organize women cancer patient advocacy session hosted by 8th Gyne-Oncology conference
Blog
Dec 22, 2024, 04:24
Jordan Rathkopf: As 2024 winds down, we’ve been reflecting on what a year it’s been